NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,125,000 | +15.4% | 106,238 | -1.9% | 0.68% | +5.9% |
Q4 2020 | $1,842,000 | -6.8% | 108,342 | -9.1% | 0.64% | -30.4% |
Q3 2020 | $1,977,000 | -29.7% | 119,198 | -1.8% | 0.92% | -34.5% |
Q2 2020 | $2,813,000 | +26.8% | 121,439 | -2.3% | 1.41% | +3.7% |
Q1 2020 | $2,219,000 | -12.8% | 124,292 | +5.4% | 1.36% | +21.7% |
Q4 2019 | $2,545,000 | +28.7% | 117,910 | +8.6% | 1.11% | +12.3% |
Q3 2019 | $1,977,000 | -42.3% | 108,540 | +12.8% | 0.99% | -42.2% |
Q2 2019 | $3,424,000 | – | 96,226 | – | 1.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |